Sample size for FDA's in vitro population BE [Power / Sample Size]

posted by ElMaestro  – Denmark, 2017-09-08 19:24 (2712 d 04:26 ago) – Posting: # 17795
Views: 9,764

Hi all,

here's the pretty solution to a terrible challenge, originating from this guidance and which is now applied to about 40 different products.

It basically involves the application of an idea that is 40 years old and which was totally impractical at the time it was invented, and using it on FDA's pop BE approach. No-one has been able to deal with it analytically because the math gets too complicated (in fact, FDA's way to calculate the confidence limit for Eta is in itself an approximation).

:-):-)

A good weekend to all of you.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,379 posts in 4,913 threads, 1,661 registered users;
257 visitors (0 registered, 257 guests [including 24 identified bots]).
Forum time: 22:50 CET (Europe/Vienna)

Science is what you know.
Philosophy is what you don’t know.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5